FIGS Stock (+11%): Q4 Earnings Beat & Strong 2026 Guidance Fuels Rally

FIGS, a direct-to-consumer healthcare apparel brand, saw its stock continue a massive rally on Monday, 3/2/2026, adding another 11% after a ~24% surge the prior session. The catalyst was a stellar Q4 2025 earnings report released after hours on Thursday, 2/26, which featured a huge beat on revenue and EPS, along with strong forward guidance for 2026 that significantly exceeded analyst expectations. The high-volume move signaled a potential fundamental re-rating, but could the post-earnings euphoria be overdone?

The Fundamental Reason

FIGS’ Q4 2025 financial results dramatically exceeded Wall Street estimates, serving as the primary stock driver. EPS hit $0.10, a 400% beat vs. $0.02 consensus. Revenue soared 33% YoY to $201.9M, crushing the ~$165M analyst estimate. This was fueled by accelerated customer acquisition & 55% international sales growth, amplified by a short squeeze.

• Q4 EPS of $0.10 massively beat the $0.02 consensus estimate.
• Q4 revenue of $201.9M (+33% YoY) surpassed the ~$165M consensus by over 22%.
• FIGS guided for FY2026 revenue growth of 10-12% (to ~$700M), well above prior consensus of ~$626M.

The Holistic Price Action Picture

Price structure tells a nuanced story beneath today’s headline move.

The current regime is classified as Trending Up: Price above rising 50D and 200D moving averages. Institutional trend appears intact.

At $17.12, the stock is 380.2% above its 52-week low of $3.57 and 1.6% below its 52-week high of $17.4.

• Trend Regime: Trending Up The 50D SMA slope stands at 2.5%, meaning the primary trend anchor is rising.
• Momentum Pulse: Accelerating: Short-term annualized return exceeding longer-term. Momentum building. The 5D return is 56.9% and 20D return is 58.4%, compared to the 63D return of 76.0% and 126D return of 139.1%.
• Key Levels to Watch: Nearest resistance sits at $23.69 (38.4% away, 2 prior touches). Nearest support is at $11.02 (35.6% below current price, 1 prior touches). The current risk/reward ratio is 1.08x – more upside to resistance than downside to support from here.
• Volatility Context: Expanded: 20D realized volatility is 94.5% annualized vs the 1-year norm of 61.9% (compression ratio: 1.53x). The daily expected move is ~5.29% of price – meaning wide swings remain the norm and trend signals should be read with caution until volatility contracts.

Understanding price structure, money flow, and price behavior can give you an edge. See more.

What Next?

The immediate technical test for FIGS is the $23.69 zone, a prior resistance level. Sustained buying at or above this zone would signal sustained momentum, but a single day’s price action doesn’t confirm a long-term trend.

To determine if this volatility is structurally justified, it is critical to evaluate the whole picture. You can weigh this recent price action against the company’s growth, multiples, margins, and core thesis at the FIGS Investment Highlights

A 10.8% single-day swing is a stark reminder of the volatility inherent in individual stock picking. While catching a surge is ideal, absorbing a similar drop is the reality of concentrated positions . For investors focused on steady compounding rather than timing specific catalysts, a balanced strategy naturally dampens this kind of single-stock whiplash. If you prefer a more systemic approach to risk management, portfolios are the structured way to handle these market cycles.

Portfolios Are The Smarter Way To Invest

Individual stocks are unpredictable. A smart portfolio helps you invest, limits downside shocks, and provides upside exposure.

The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? HQ Portfolio has posted more than 105% in cumulative return since inception, with less risk versus the benchmark index, as evident in HQ Portfolio performance metrics.